CQS New City High Yield Fund Revenu
Quel est le Revenu de CQS New City High Yield Fund?
Le Revenu de CQS New City High Yield Fund Ltd. est £8.238M
Quelle est la définition de Revenu?
Le revenu est le revenu qu'une entreprise tire de ses activités commerciales normales, généralement de la vente de biens et de services aux clients.
Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.
In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.
Revenu des entreprises dans Finance secteur sur LSE par rapport à CQS New City High Yield Fund
Que fait CQS New City High Yield Fund?
CQS New City High Yield Fund Limited is a close ended fixed income mutual fund launched by CQS Asset Management Ltd. The fund is managed by CQS (UK) LLP. It invests in fixed income markets. The fund primarily invests in fixed income securities such as corporate and government bonds, loan stocks, and high yielding bonds. It uses a value approach to create its portfolio. The fund was formerly known as New City High Yield Fund Limited. CQS New City High Yield Fund Limited was formed in October 2004 and is domiciled in the Channel Islands.
Entreprises avec revenu similaire à CQS New City High Yield Fund
- Spectur a Revenu de AUD$8.180M
- Ocugen Inc a Revenu de $8.191M
- Safe & Green Corp a Revenu de $8.193M
- Timah Resources a Revenu de RM8.200M
- cyan AG a Revenu de €8.200M
- Mereo BioPharma plc a Revenu de £8.231M
- CQS New City High Yield Fund a Revenu de £8.238M
- InCity Immobilien AG a Revenu de €8.275M
- Ariadne Australia a Revenu de AUD$8.280M
- Dev Clever Plc a Revenu de £8.284M
- Cue Biopharma Inc a Revenu de $8.296M
- Celldex Therapeutics a Revenu de $8.302M
- RAS Technology Ltd a Revenu de AUD$8.328M